PERIPHERAL 15-Year Patency and Life Expectancy After Primary Stenting Guided by Intravascular Ultrasound for Iliac Artery Lesions in Peripheral Arterial Disease

T he therapeutic strategy for peripheral arterial disease (PAD) is generally selected based on the lesion type, using the morphological stratification in the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TransAtlantic Inter-Society Consensus [TASC]) classification in the aortoiliac artery (1). Favorable results have been obtained with endovascular treatment (EVT) for iliac artery lesions compared with lesions of the femoral artery (2–4). However, there are few